Mometasonfuroaat Basic Pharma (Mometasone Furoate Monohydrate)

Mometasone furoate, the active ingredient in Mometasonfuroaat Basic Pharma, is a corticosteroid presented as a nasal spray formulation for intranasal use. It treats allergic rhinitis, both seasonal and perennial, by reducing inflammation in the nasal passages of adults and children, helping improve airflow and symptom relief.

GNH USA supplies Mometasonfuroaat Basic Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance, and reliable logistics to meet global market demands.

Mometasone furoate nasal spray acts on the inflammatory pathway of the nasal mucosa to relieve symptoms of allergic conditions.

Allergic rhinitis: reduces nasal inflammation, alleviating congestion, sneezing and itching. Seasonal allergic rhinitis: provides symptom control during pollen seasons. Perennial allergic rhinitis: helps manage year‑round nasal allergy symptoms.

Common Side Effects: - Nasal irritation or burning sensation - Epistaxis (nosebleeds) - Headache - Sore throat or cough - Altered taste or smell - Nasal dryness

Serious or Rare Side Effects: - Nasal septal perforation - Cataracts or glaucoma with prolonged use - Adrenal suppression - Opportunistic fungal infection of the nasal passages - Severe allergic reaction (anaphylaxis)

Mometasone furoate nasal spray should be used with caution in specific situations. - Pregnancy: consult a healthcare professional before use. - Lactation: discuss potential risks with a physician. - Elderly patients: monitor for systemic corticosteroid effects. - Concurrent nasal surgery: postpone use until healing is complete. - Overuse: adhere to prescribed dosing frequency. - Store at room temperature: keep in the original container, protect from moisture and direct heat.

Mometasone furoate nasal spray may interact with other medications.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug exposure.

Moderate Interactions (Monitor Closely): - Antihistamines: additive relief of allergic symptoms. - Anticholinergic nasal sprays: may increase nasal dryness. - Nasal decongestants: potential for increased local irritation. - Antifungal agents: monitor for fungal colonisation when used together.